Ilic I, Ilic M (2022) International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: a joinpoint regression analysis. World J Gastroenterol 28(32):4698

PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer J Clin 71(3):209–49

Google Scholar 

Qian L, Li Q, Baryeh K, Qiu W, Li K, Zhang J, Yu Q, Xu D, Liu W, Brand RE, Zhang X (2019) Biosensors for early diagnosis of pancreatic cancer: a review. Transl Res 1(213):67–89

Google Scholar 

Bazeed AY, Day CM, Garg S (2022) Pancreatic cancer: challenges and opportunities in locoregional therapies. Cancers 14(17):4257

PubMed  PubMed Central  CAS  Google Scholar 

Zakeri-Milani P, Farkhani SM, Shirani A, Mohammadi S, Mojarrad JS, Akbari J, Valizadeh H (2017) Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides. EXCLI J 16:650

PubMed  PubMed Central  Google Scholar 

Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A (2020) Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci 20(7):193

Google Scholar 

Sharma P, Akram W, Jain V, Tailang M (eds) (2024) Smart nanocarrier for effective drug delivery. CRC Press

Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T (2023) Nanomedicine in cancer therapy. Signal Transduct Target Ther 8(1):293

PubMed  PubMed Central  Google Scholar 

Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 16:1–33

Google Scholar 

Sharma P, Dasputre N, Jain V. Nanomedicine: concepts, characteristics, and regulatory challenges. InSmart Nanocarrier for Effective Drug Delivery. CRC Press, pp 1–16

Giordano G, Pancione M, Olivieri N, Parcesepe P, Velocci M, Di Raimo T, Coppola L, Toffoli G, D’Andrea MR (2017) Nano albumin bound-paclitaxel in pancreatic cancer: current evidences and future directions. World J Gastroenterol 23(32):5875

PubMed  PubMed Central  CAS  Google Scholar 

Sharma P (2023) Nanostructured biomaterials in drug delivery: current trends and upcoming possibilities. In: Engineered biomaterials: synthesis and applications. Springer Nature Singapore, Singapore, pp 261–280

Prajapati A, Rangra S, Patil R, Desai N, Jyothi VG, Salave S, Amate P, Benival D, Kommineni N (2024) Receptor-targeted nanomedicine for cancer therapy. Receptors 3(3):323–361

Google Scholar 

Takemoto H, Inaba T, Nomoto T, Matsui M, Liu X, Toyoda M, Honda Y, Taniwaki K, Yamada N, Kim J, Tomoda K (2020) Polymeric modification of gemcitabine via cyclic acetal linkage for enhanced anticancer potency with negligible side effects. Biomaterials 1(235):119804

Google Scholar 

Parida RC, Thamizhanban D, Jena GK (2025) Quality by design approach for the development of polymeric nanoparticles: a focus on capecitabine. Curr Nanomater

Patnaik A, Jena GK, Patra CN (2023) Recent advancements and patent search on polymeric nanoparticles. BioNanoScience 13(4):1463–1469

Google Scholar 

Scherließ R, Janke J (2021) Preparation of poly-lactic-co-glycolic acid nanoparticles in a dry powder formulation for pulmonary antigen delivery. Pharmaceutics 13(8):1196

PubMed  PubMed Central  Google Scholar 

Walia N, Zhang S, Wismer W, Chen L (2022) A low energy approach to develop nanoemulsion by combining pea protein and Tween 80 and its application for vitamin D delivery. Food Hydrocolloids for Health 1(2):100078

Google Scholar 

Gajbhiye KR, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V (2023) Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Mol Cancer 22(1):160

PubMed  PubMed Central  Google Scholar 

Jia L, Zheng JJ, Jiang SM, Huang KH (2010) Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles. World J Gastroenterol: WJG 16(8):1008

PubMed  PubMed Central  CAS  Google Scholar 

Abdelwahed W, Degobert G, Stainmesse S, Fessi H (2006) Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 58(15):1688–1713

PubMed  CAS  Google Scholar 

Subhan MA, Yalamarty SS, Filipczak N, Parveen F, Torchilin VP (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Personalized Med 11(6):571

Google Scholar 

Wang YJ, Chien YC, Wu CH, Liu DM (2011) Magnolol-loaded core–shell hydrogel nanoparticles: drug release, intracellular uptake, and controlled cytotoxicity for the inhibition of migration of vascular smooth muscle cells. Mol Pharm 8(6):2339–49

PubMed  CAS  Google Scholar 

Sharma P, Tailang M (2022) Primaquine-loaded transdermal patch for treating malaria: design, development, and characterization. Futur J Pharm Sci 8(1):43

Google Scholar 

Sharma P, Tailang M (2020) Design, optimization, and evaluation of hydrogel of primaquine loaded nanoemulsion for malaria therapy. Futur J Pharm Sci 6:1–1

Google Scholar 

Ojha C, Sharma P, Jain V (2024) Design, optimization, and evaluation of topical gel of Cardiospermum halicacabum and Ricinus communis L. leaves extract for the treatment of rheumatoid arthritis. J Biomater Sci, Polym Edn 1–22

González-González O, Ramirez IO, Ramirez BI, O’Connell P, Ballesteros MP, Torrado JJ, Serrano DR (2022) Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics 14(11):2324

PubMed  PubMed Central  Google Scholar 

Sharma A, Shambhwani D, Pandey S, Singh J, Lalhlenmawia H, Kumarasamy M, Singh SK, Chellappan DK, Gupta G, Prasher P, Dua K (2022) Advances in lung cancer treatment using nanomedicines. ACS Omega 8(1):10–41

PubMed  PubMed Central  Google Scholar 

Zhang H, Yan S, Zhan Y, Ma S, Bian Y, Li S, Tian J, Li G, Zhong D, Diao X, Miao L (2023) A mass balance study of [14C] SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans. Front Pharmacol 31(14):1116073

Google Scholar 

Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N, Huang C, Shen Z (2022) Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J Hematol Oncol 15(1):132

PubMed  PubMed Central  Google Scholar 

Soares GA, Pereira GM, Romualdo GR, Biasotti GG, Stoppa EG, Bakuzis AF, Baffa O, Barbisan LF, Miranda JR (2022) Biodistribution profile of magnetic nanoparticles in cirrhosis-associated hepatocarcinogenesis in rats by AC biosusceptometry. Pharmaceutics 14(9):1907

PubMed  PubMed Central  CAS  Google Scholar 

Liu S, Jing Y, Liu G (2024) A systematic investigation of the kinetic models applied to the transport behaviors of aromatic solvents in unfilled hydrogenated nitrile rubber/ethylene propylene diene monomer composites. Polymers 16(7):892

PubMed  PubMed Central  CAS  Google Scholar 

Zothanpuii F, Rajesh R, Selvakumar KJ (2020) A review on stability testing guidelines of pharmaceutical products. Asian J Pharm Clin Res 13(10):3–9

CAS  Google Scholar 

Chen Q, Yuan L, Chou WC, Cheng YH, He C, Monteiro-Riviere NA, Riviere JE, Lin Z (2023) Meta-analysis of nanoparticle distribution in tumors and major organs in tumor-bearing mice. ACS Nano 17(20):19810–19831

PubMed  PubMed Central  CAS  Google Scholar 

Vogel A, Römmler-Zehrer J, Li JS, McGovern D, Romano A, Stahl M (2016) Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT). BMC Cancer 16:1

Google Scholar 

Yu J, Xu X, Griffin JI, Mu Q, Ho RJ (2024) Drug Combination nanoparticles containing gemcitabine and paclitaxel enable orthotopic 4T1 breast tumor regression. Cancers 16(16):2792

PubMed  PubMed Central  CAS  Google Scholar 

Jena GK, Patra CN, Panigrahi KC, Sruti J, Patra P, Parhi R (2022) QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity. Drug Deliv Transl Res 12(6):1521–1539

PubMed  CAS  Google Scholar